Fundz
Real-time · AI · Cross-signal

Cyclacel Pharmaceuticals just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Cyclacel Pharmaceuticals, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
▶
Watch the 2-minute tour · with sound

Bio Green Med Solution Enters Warrant Exchange Agreement

Nov 06, 2025•7 months ago

Contract Type

warrant_exchange_agreement

Berkeley HeightsBiotechnologyTherapeuticsPharmaceuticalBiopharma

Description

On November 5, 2025, Bio Green Med Solution, Inc. entered into a Warrant Exchange Agreement with certain accredited investors. This agreement involves the exchange of existing warrants held by the investors for new warrants. The total number of warrants related to the agreement amounts to 1,402,605 shares of the company's common stock.

Company Information

Company

Cyclacel Pharmaceuticals

Location

200 CONNELL DRIVE, SUITE 1500

Berkeley Heights, New Jersey, United States

About

Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis biology. The Company's strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications.

Predictive Intelligence
Strategic

ML-powered predictions for Cyclacel Pharmaceuticals's next move

Learn about Strategic plan

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months